BR112016024400A2 - uso de niacinamida, niacinamida e método para melhorar a proteção do couro cabeludo - Google Patents

uso de niacinamida, niacinamida e método para melhorar a proteção do couro cabeludo

Info

Publication number
BR112016024400A2
BR112016024400A2 BR112016024400A BR112016024400A BR112016024400A2 BR 112016024400 A2 BR112016024400 A2 BR 112016024400A2 BR 112016024400 A BR112016024400 A BR 112016024400A BR 112016024400 A BR112016024400 A BR 112016024400A BR 112016024400 A2 BR112016024400 A2 BR 112016024400A2
Authority
BR
Brazil
Prior art keywords
niacinamide
scalp protection
improve scalp
skin
improve
Prior art date
Application number
BR112016024400A
Other languages
English (en)
Inventor
Majumdar Amitabha
Palanisamy Bharath
Kumar Tiwari Jyoti
Swamy Mathapathi Mruthyunjaya
Sampatha Kumar Ramya
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of BR112016024400A2 publication Critical patent/BR112016024400A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

a invenção refere-se a um novo uso de niacinamida para ativação de geração de amps (peptídeos anti-microbiais) na pele. isso apresenta aplicação na melhora da imunidade da pele, couro cabeludo e cavidade oral contra o ataque de microorganismos.
BR112016024400A 2014-05-12 2014-05-12 uso de niacinamida, niacinamida e método para melhorar a proteção do couro cabeludo BR112016024400A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2014/059590 WO2015172801A1 (en) 2014-05-12 2014-05-12 Niacinamide for inducing generation of antimicrobial peptides

Publications (1)

Publication Number Publication Date
BR112016024400A2 true BR112016024400A2 (pt) 2017-08-15

Family

ID=50771476

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016024400A BR112016024400A2 (pt) 2014-05-12 2014-05-12 uso de niacinamida, niacinamida e método para melhorar a proteção do couro cabeludo

Country Status (8)

Country Link
JP (1) JP6446065B2 (pt)
CN (2) CN106413680A (pt)
BR (1) BR112016024400A2 (pt)
EA (1) EA031758B1 (pt)
MX (1) MX2016014760A (pt)
PH (1) PH12016502047A1 (pt)
WO (1) WO2015172801A1 (pt)
ZA (1) ZA201607105B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10722436B2 (en) 2015-08-10 2020-07-28 Mary Kay Inc. Topical compositions
EA035789B1 (ru) 2015-10-05 2020-08-11 Юнилевер Н.В. Композиция, содержащая ниацинамид и пиколинамид
CN109069422B (zh) * 2016-05-10 2023-10-24 联合利华知识产权控股有限公司 局部抗微生物组合物
CA3023369A1 (en) 2016-05-26 2017-11-30 Unilever Plc Antimicrobial compositions for topical use
EP3426276B1 (en) 2017-05-24 2024-01-24 Follea International Synephrine compositions
BR112020008561A2 (pt) * 2017-10-30 2020-10-06 Unilever Nv usos de niacinamidas, niacinamidas, composição e método de fornecimento de proteção
WO2019121529A1 (en) 2017-12-18 2019-06-27 Unilever N.V. A topical composition
WO2019121548A1 (en) 2017-12-18 2019-06-27 Unilever N.V. A topical composition based on niacinamide derivative
US20200404915A1 (en) 2018-03-13 2020-12-31 Conopco, Inc., D/B/A Unilever A sanitizer composition
WO2024042554A1 (en) * 2022-08-25 2024-02-29 Istituto Fondazione Di Oncologia Molecolare Ets A pharmaceutical composition for treatment of viral infections
WO2024041911A1 (en) * 2022-08-25 2024-02-29 Unilever Ip Holdings B.V. A nasal drop composition and device thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN892496A0 (en) * 1996-03-25 1996-04-18 Technical Consultancy Services Pty Limited Acne treatment
US7026308B1 (en) * 1999-06-25 2006-04-11 The Procter & Gamble Company Topical anti-microbial compositions
MX2007004280A (es) * 2004-10-15 2007-05-16 Bayer Consumer Care Ag Composiciones acidas y tamponadas para el cuidado de la piel que comprenden nicotinamida y un agente absorbente.
CN101019865A (zh) * 2007-01-23 2007-08-22 中国医学科学院皮肤病医院 抗炎、保湿、祛斑的复方烟酰胺药用组合物
US20130052162A1 (en) * 2010-04-20 2013-02-28 Cedars-Sinai Medical Center Boosting immune defense by upregulating ccaat/enhancer binding protein epsilon
CA2814135A1 (en) * 2010-10-10 2012-04-19 Dermipsor Ltd. Compositions for treating psoriasis of the scalp
FR2973699B1 (fr) * 2011-04-05 2013-04-26 Oreal Nouvel actif apte a induire au stimuler la production de peptides anti microbiens dans le cuir chevelu, utile pour prevenir et/ou traiter les etats pelliculaires du cuir chevelu
US8293790B2 (en) * 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
DE102012002592A1 (de) * 2012-02-13 2013-08-14 Dr. Kurt Wolff Gmbh & Co. Kg Verwendung eines Mittels zur Stimulation der Gen-Expression antimikrobieller Peptide (AMP)
CN104363907A (zh) * 2012-06-15 2015-02-18 康纳里斯研究院股份公司 用于正面影响肠道微生物丛的含有烟酸和/或烟酰胺和/或色氨酸的药物组合物
EP3120850B1 (en) * 2012-12-14 2018-11-07 Unilever N.V. Niacinamide for inducing generation of antimicrobial peptides

Also Published As

Publication number Publication date
EA031758B1 (ru) 2019-02-28
EA201692284A1 (ru) 2017-03-31
JP2017515829A (ja) 2017-06-15
MX2016014760A (es) 2017-03-06
ZA201607105B (en) 2018-05-30
WO2015172801A1 (en) 2015-11-19
CN113908074A (zh) 2022-01-11
CN106413680A (zh) 2017-02-15
JP6446065B2 (ja) 2018-12-26
PH12016502047A1 (en) 2017-01-09

Similar Documents

Publication Publication Date Title
BR112016024400A2 (pt) uso de niacinamida, niacinamida e método para melhorar a proteção do couro cabeludo
EP4282479A3 (en) Use of pridopidine to treat depression or anxiety
EP3354257A4 (en) COMPOSITION FOR IMPROVING SKIN AND PREVENTING HAIR LOSS WITH EXTRACELLULAR VESICLES FROM PLANT EXTRACTS
AU2015296298A8 (en) Flagellin-based agents and uses including effective vaccination
EP3295404A4 (en) MISSING OF INTENTIONS IN TRANSACTIONS USING ENCRYPTION TECHNIQUES
AR102657A1 (es) Composición para tratar telas
PH12015501720B1 (en) Modulators of methyl modifying enzymes, compositions and uses thereof
BR112017008726A2 (pt) usos de um extrato de fermento e de um exopolissacarídeo, e, composição cosmética.
MX2020005446A (es) Metodos para marcar una molecula deuterada o no deuterada y formulaciones farmaceuticas para tratamiento.
EP3604535A3 (en) Methods and compositions for weed control
EP3300731A4 (en) HAIR-REPAIRING / GROWTH-STIMULATING ACTIVE AGENT
EP3139939A4 (en) Compositions and methods for treating skin and mucous membrane diseases
GEP20197049B (en) Compositions and methods for treating surface wounds
CR20160044S (es) Dispensador de jabon
BR112018070188A2 (pt) uso de caulim como opacificante
BR112017004197A2 (pt) composições de vacina contra doenças do vírus da dengue
BR112016030758B8 (pt) Uso de células estromais multipotentes derivadas de tecido adiposo mesenquimal
PH12016500465B1 (en) Deoxynojirimycin derivatives and methods of their using
EA201790461A1 (ru) Композиции внеклеточного матрикса
MX2017000374A (es) Metodos y composiciones que regulan el crecimiento del pelo.
EP3137082A4 (en) Methods to treat, prevent, and improve skin conditions
MX2014009750A (es) Composiciones antifungicas para el tratamiento de piel y uñas.
MX359181B (es) Hidrolizado de colágeno y uso del mismo.
MX368582B (es) Extracto de gardenia para colorear la piel.
MX2015015428A (es) Eliminacion de riesgo de narcolepsia en vacunas contra influenza.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]